Physiological and pathological implications of 5-hydroxymethylcytosine in diseases
Open Access
- 10 May 2016
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (30) , 48813-48831
Abstract
Physiological and pathological implications of 5-hydroxymethylcytosine in diseasesKeywords
This publication has 190 references indexed in Scilit:
- MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous SystemCell, 2012
- Subcutaneous 5-Azacitidine Treatment of Naturally Occurring Canine Urothelial Carcinoma: A Novel Epigenetic Approach to Human Urothelial Carcinoma Drug DevelopmentJournal of Urology, 2012
- Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation developmentCell Research, 2011
- Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal DevelopmentCell Stem Cell, 2011
- Genome-wide Regulation of 5hmC, 5mC, and Gene Expression by Tet1 Hydroxylase in Mouse Embryonic Stem CellsMolecular Cell, 2011
- Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult BrainCell, 2011
- Regulation and function of DNA methylation in plants and animalsCell Research, 2011
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2Nature, 2010
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specificationNature, 2010
- Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiencyNature, 2010